Specifically, TAU1 has been reported to label P-tau in the 3xTg-AD mouse model, opening up avenues for the cost-effective monitoring of the tau protein aggregation state in animal models and possibly in human fixed tissue staining37. This evidence concerns the gene MAPT and Alzheimer disease.